JPRN-UMIN000004390已完成未知
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitus - The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitus
Cardiovascular Division, Hyogo College of Medicine0 个研究点目标入组 40 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Target lesion is left main coronary artery 2) Patients on hemodialysis 3) Patients with acute coronary syndorome 4) Patients with contraindication of antiplatelet or anticoagulation drug 5) Patients who are uncontrolled diabetes mellitus 6) Patients who are judged by the principal investigator to be ineligible for enrollment in the study
研究者
相似试验
招募中
不适用
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysisType 2 diabetic patients on hemodialysisJPRN-UMIN000006024Chibune general hospital5
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
尚未招募
不适用
Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabeticsdiabetic patientJPRN-jRCT1091220223Bonpei Takase30
招募中
不适用
Investigation of the impact of DPP-4 inhibition on serum brain natriuretic peptide level of diabetic patients with congestive heart failure.JPRN-UMIN000015685Mitsui Memorial Hospital50